Meacor Overview
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$15M
- Investors
-
8
Meacor General Information
Description
Developer of a catheter-based medical device designed to repair the mitral and tricuspid valves. The company develops an anchoring catheter system used to treat heart disease with a special focus on transcatheter interventions, which have reduced risks and trauma associated with conventional surgery, enabling patients who are not surgical candidates to be effectively treated for mitral valve regurgitation.
Contact Information
Website
www.meacor.comCorporate Office
- 199 Technology Drive
- Suite 100
- Irvine, CA 92618
- United States
Corporate Office
- 199 Technology Drive
- Suite 100
- Irvine, CA 92618
- United States
Meacor Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series A) | 13-May-2024 | $15M | Completed | Pre-Clinical Trials | ||
| 7. Accelerator/Incubator | 01-Jun-2022 | Completed | Pre-Clinical Trials | |||
| 6. Seed Round | 31-May-2021 | Completed | Product In Beta Test | |||
| 5. Angel (individual) | 08-Jan-2018 | Completed | Product In Beta Test | |||
| 4. Accelerator/Incubator | 01-Jan-2018 | Completed | Product In Beta Test | |||
| 3. Seed Round | 28-Jun-2016 | Completed | Product In Beta Test | |||
| 2. Grant | 26-Jun-2014 | Completed | Product In Beta Test | |||
| 1. Accelerator/Incubator | 01-Jan-2014 | Completed | Startup |
Meacor Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 25,000,000 | $0.000100 | $0.8 | $0.8 | 1x | $0.8 | 30.98% | |
| Seed | 5,202,001 | $0.000100 | $0.15 | $0.15 | 1x | $0.15 | 10.4% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Meacor Patents
Meacor Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4598452-A2 | Transcatheter or minimally invasive surgery system and methods of using same | Pending | 08-Oct-2022 | ||
| EP-4598452-A4 | Transcatheter or minimally invasive surgery system and methods of using same | Pending | 08-Oct-2022 | ||
| US-20250325319-A1 | Transcatheter or minimally invasive surgery system and methods of using same | Pending | 08-Oct-2022 | ||
| WO-2024077279-A2 | Transcatheter or minimally invasive surgery system and methods of using same | Inactive | 08-Oct-2022 | ||
| WO-2024077279-A3 | Transcatheter or minimally invasive surgery system and methods of using same | Inactive | 08-Oct-2022 | A61M25/0043 |
Meacor Signals
Meacor Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | Minority | ||
| Kafalat | Lender/Debt Provider | Minority | ||
| BigBooster | Accelerator/Incubator | |||
| Berytech | Accelerator/Incubator | Minority | ||
| IM Fndng | Venture Capital | Minority |
Meacor FAQs
-
Where is Meacor headquartered?
Meacor is headquartered in Irvine, CA.
-
What is the size of Meacor?
Meacor has 4 total employees.
-
What industry is Meacor in?
Meacor’s primary industry is Surgical Devices.
-
Is Meacor a private or public company?
Meacor is a Private company.
-
What is the current valuation of Meacor?
The current valuation of Meacor is .
-
What is Meacor’s current revenue?
The current revenue for Meacor is .
-
How much funding has Meacor raised over time?
Meacor has raised $16.2M.
-
Who are Meacor’s investors?
MedTech Innovator, Kafalat, BigBooster, Berytech, and IM Fndng are 5 of 8 investors who have invested in Meacor.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process